Novel myeloperoxidase-derived HLA-A2-restricted peptides as therapeutic targets against myeloid leukemia-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Novel myeloperoxidase-derived HLA-A2-restricted peptides as therapeutic targets against myeloid leukemia

Published:2021-09 Issue:9 Volume:23 Page:793-798
ISSN:1465-3249
Container-title:Cytotherapy
language:en
Short-container-title:Cytotherapy

Author:

Lu Sijie,Tallis Eran,Ding Xiaoling,Li Dan,Cox Kathryn,You M. James,St John Lisa,Alatrash Gheath,Ma Qing,Molldrem Jeffrey J.

Funder

NIH

National Cancer Institute

Publisher

Elsevier BV

Subject

Cancer Research,Transplantation,Cell Biology,Genetics(clinical),Oncology,Immunology,Immunology and Allergy

Reference18 articles.

1. An update of current treatments for adult acute myeloid leukemia;Dombret;Blood,2016

2. Hematopoietic stem cell transplantation for patients with AML in first complete remission;Cornelissen;Blood,2016

3. Targeted T-cell therapy for human leukemia: cytotoxic T lymphocytes specific for a peptide derived from proteinase 3 preferentially lyse human myeloid leukemia cells;Molldrem;Blood,1996

4. A novel HLA-A*0201 restricted peptide derived from cathepsin G is an effective immunotherapeutic target in acute myeloid leukemia;Zhang;Clin Cancer Res,2013

5. Myeloperoxidase: a front-line defender against phagocytosed microorganisms;Klebanoff;J Leuk Bio,2013

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. GPC3 Promotes Lung Squamous Cell Carcinoma Progression and HLA-A2-Restricted GPC3 Antigenic Peptide-Modified Dendritic Cell-Induced Cytotoxic T Lymphocytes to Kill Lung Squamous Cell Carcinoma Cells;Journal of Immunology Research;2023-11-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP